• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用宽带介电谱研究非晶态药物非诺贝特的分子动力学。

Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy.

作者信息

Sailaja U, Thayyil M Shahin, Kumar N S Krishna, Govindaraj G

机构信息

Department of Physics, M.E.S Keveeyam College, Valanchery, 676552 Malappuram, Kerala, India.

Department of Physics, University of Calicut, 673635 Kerala, India.

出版信息

J Pharm Anal. 2016 Jun;6(3):165-170. doi: 10.1016/j.jpha.2014.09.003. Epub 2014 Sep 16.

DOI:10.1016/j.jpha.2014.09.003
PMID:29403977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5762493/
Abstract

Fenofibrate is mainly used to reduce cholesterol level in patients at risk of cardiovascular disease. Thermal transition study with the help of differential scanning calorimetry (DSC) shows that the aforesaid active pharmaceutical ingredient (API) is a good glass former. Based on our DSC study, the molecular dynamics of this API has been carried out by broadband dielectric spectroscopy (BDS) covering wide temperature and frequency ranges. Dielectric measurements of amorphous fenofibrate were performed after its vitrification by fast cooling from a few degrees above the melting point (=354.11 K) to deep glassy state. The sample does not show any crystallization tendency during cooling and reaches the glassy state. The temperature dependence of the structural relaxation has been fitted by single Vogel-Fulcher-Tamman (VFT) equation. From VFT fit, glass transition temperature () was estimated as 250.56 K and fragility () was determined as 94.02. This drug is classified as a fragile glass former. Deviations of experimental data from Kohlrausch-Williams-Watts (KWW) fits on high-frequency flank of α-peak indicate the presence of an excess wing in fenofibrate. Based on Ngai׳s coupling model, we identified the excess wing as true Johari-Goldstein (JG) process. Below the glass transition temperature one can clearly see a secondary relaxation (γ) with an activation energy of 32.67 kJ/mol.

摘要

非诺贝特主要用于降低有心血管疾病风险患者的胆固醇水平。借助差示扫描量热法(DSC)进行的热转变研究表明,上述活性药物成分(API)是一种良好的玻璃态形成剂。基于我们的DSC研究,通过覆盖宽温度和频率范围的宽带介电谱(BDS)对该API的分子动力学进行了研究。将非晶态非诺贝特从熔点以上几度(=354.11 K)快速冷却至深玻璃态进行玻璃化后,进行了介电测量。样品在冷却过程中未显示出任何结晶趋势,并达到了玻璃态。结构弛豫的温度依赖性已通过单一的Vogel-Fulcher-Tamman(VFT)方程进行拟合。通过VFT拟合,玻璃化转变温度()估计为250.56 K,脆性()确定为94.02。这种药物被归类为易碎玻璃态形成剂。实验数据与α峰高频侧翼上的Kohlrausch-Williams-Watts(KWW)拟合的偏差表明非诺贝特中存在过量翼。基于Ngai的耦合模型,我们将过量翼识别为真正的Johari-Goldstein(JG)过程。在玻璃化转变温度以下,可以清楚地看到具有32.67 kJ/mol活化能的二级弛豫(γ)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/bce53b234300/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/a725164a1081/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/eef6a5f1180c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/5f6d871dc8a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/759fe777771c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/76b2a72c9a80/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/3545fdf4c597/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/f962e6b34c04/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/bce53b234300/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/a725164a1081/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/eef6a5f1180c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/5f6d871dc8a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/759fe777771c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/76b2a72c9a80/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/3545fdf4c597/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/f962e6b34c04/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaa/5762493/bce53b234300/gr8.jpg

相似文献

1
Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy.用宽带介电谱研究非晶态药物非诺贝特的分子动力学。
J Pharm Anal. 2016 Jun;6(3):165-170. doi: 10.1016/j.jpha.2014.09.003. Epub 2014 Sep 16.
2
Dielectric relaxation studies and dissolution behavior of amorphous verapamil hydrochloride.无定形盐酸维拉帕米的介电松弛研究及溶解行为。
J Pharm Sci. 2010 Feb;99(2):828-39. doi: 10.1002/jps.21877.
3
Molecular dynamics in liquid and glassy states of non-steroidal anti-inflammatory drug: ketoprofen.非甾体抗炎药:酮洛芬液态和玻璃态中的分子动力学。
Eur J Pharm Sci. 2013 May 13;49(2):333-40. doi: 10.1016/j.ejps.2013.03.017. Epub 2013 Apr 4.
4
Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.非晶态S-氟比洛芬的分子流动性:一种介电弛豫光谱方法。
Mol Pharm. 2014 Jan 6;11(1):112-30. doi: 10.1021/mp4002188. Epub 2013 Nov 22.
5
Molecular mobility in liquid and glassy states of telmisartan (TEL) studied by broadband dielectric spectroscopy.用宽频介电谱研究替米沙坦(TEL)在液态和玻璃态下的分子迁移率。
Eur J Pharm Sci. 2009 Nov 5;38(4):395-404. doi: 10.1016/j.ejps.2009.09.009. Epub 2009 Sep 17.
6
Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.非晶态药物分子流动性及等温结晶动力学的介电研究
J Pharm Sci. 2004 Jan;93(1):218-33. doi: 10.1002/jps.10520.
7
Molecular Relaxations in Supercooled Liquid and Glassy States of Amorphous Quinidine: Dielectric Spectroscopy and Density Functional Theory Approaches.非晶态奎尼丁过冷液态和玻璃态中的分子弛豫:介电谱和密度泛函理论方法
J Phys Chem B. 2016 Aug 4;120(30):7579-92. doi: 10.1021/acs.jpcb.6b04242. Epub 2016 Jul 27.
8
Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT) and the Onset of Crystallization.药物共无定形系统的分子动力学和物理稳定性:通过 Kohlrausch-Williams-Watts 测量的结构弛豫时间与玻璃化转变温度(ΔT)的宽度和结晶起始的相关性。
J Pharm Sci. 2019 Dec;108(12):3848-3858. doi: 10.1016/j.xphs.2019.09.013. Epub 2019 Sep 19.
9
Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.三种具有药用活性的苯并二氮杂䓬衍生物的比较物理研究:晶态与无定形态及结晶趋势。
Mol Pharm. 2021 Apr 5;18(4):1819-1832. doi: 10.1021/acs.molpharmaceut.1c00081. Epub 2021 Mar 9.
10
Application of advanced thermal analysis for characterization of crystalline and amorphous phases of carvedilol.应用先进的热分析技术对卡维地洛的晶相和非晶相进行表征。
J Pharm Biomed Anal. 2022 Aug 5;217:114822. doi: 10.1016/j.jpba.2022.114822. Epub 2022 May 7.

引用本文的文献

1
Effects of hydrostatic compression and kinetic vitrification on structural relaxation behaviors of amorphous drugs: how to predict them simple theoretical models?静水压压缩和动态玻璃化对无定形药物结构松弛行为的影响:如何用简单理论模型预测它们?
RSC Adv. 2025 Jul 18;15(31):25675-25693. doi: 10.1039/d5ra03931b. eCollection 2025 Jul 15.
2
Preparation and Characterization of Fenofibrate-Loaded Fibers Based on 2-Hydroxylpropyl-β-Cyclodextrin.基于2-羟丙基-β-环糊精的非诺贝特载药纤维的制备与表征
Polymers (Basel). 2025 Apr 11;17(8):1037. doi: 10.3390/polym17081037.
3
Significantly improving the solubility and anti-inflammatory activity of fenofibric acid with native and methyl-substituted beta-cyclodextrins via complexation.

本文引用的文献

1
Molecular dynamics, physical stability and solubility advantage from amorphous indapamide drug.分子动力学、物理稳定性和无定形吲达帕胺药物的溶解度优势。
Mol Pharm. 2013 Oct 7;10(10):3612-27. doi: 10.1021/mp400116q. Epub 2013 Sep 26.
2
Molecular dynamics in liquid and glassy states of non-steroidal anti-inflammatory drug: ketoprofen.非甾体抗炎药:酮洛芬液态和玻璃态中的分子动力学。
Eur J Pharm Sci. 2013 May 13;49(2):333-40. doi: 10.1016/j.ejps.2013.03.017. Epub 2013 Apr 4.
3
Computational approach for fast screening of small molecular candidates to inhibit crystallization in amorphous drugs.
通过络合作用,利用天然和甲基取代的β-环糊精显著提高非诺贝特酸的溶解度和抗炎活性。
Sci Rep. 2025 Jan 5;15(1):853. doi: 10.1038/s41598-024-84745-x.
4
Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles.了解非诺贝特从裸露和改性介孔二氧化硅纳米颗粒中的释放情况。
Pharmaceutics. 2023 May 30;15(6):1624. doi: 10.3390/pharmaceutics15061624.
5
Towards controlling the crystallisation behaviour of fenofibrate melt: triggers of crystallisation and polymorphic transformation.关于控制非诺贝特熔体的结晶行为:结晶触发因素及多晶型转变
RSC Adv. 2018 Apr 10;8(24):13513-13525. doi: 10.1039/c8ra01182f. eCollection 2018 Apr 9.
6
Molecular dynamics and the translational-rotational coupling of an ionically conducting glass-former: amlodipine besylate.分子动力学与离子导电玻璃形成体的平动-转动耦合:苯磺酸氨氯地平
RSC Adv. 2018 Jun 6;8(37):20630-20636. doi: 10.1039/c8ra01544a. eCollection 2018 Jun 5.
7
Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form.三元共晶ezetimibe-辛伐他汀-非诺贝特系统及其无定形形式的物理稳定性。
Mol Pharm. 2021 Sep 6;18(9):3588-3600. doi: 10.1021/acs.molpharmaceut.1c00485. Epub 2021 Aug 22.
8
Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.用于静脉注射疏水性活性药物成分的非溶血性纳米乳剂的设计
Pharmaceutics. 2020 Nov 25;12(12):1141. doi: 10.3390/pharmaceutics12121141.
9
Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets.非诺贝特负载的聚乙烯吡咯烷酮静电纺丝微纤维片的制备与表征
Pharmaceutics. 2020 Jun 30;12(7):612. doi: 10.3390/pharmaceutics12070612.
计算方法快速筛选小分子候选物以抑制无定形药物结晶。
Mol Pharm. 2012 Oct 1;9(10):2844-55. doi: 10.1021/mp300135h. Epub 2012 Aug 27.
4
Molecular dynamics at ambient and elevated pressure of the amorphous pharmaceutical: nonivamide (pelargonic acid vanillylamide).无定形药物:辣椒素(壬酸香草酰胺)在环境和高压下的分子动力学。
J Chem Phys. 2011 Jan 28;134(4):044517. doi: 10.1063/1.3543711.
5
Effect of pressure on tautomers' equilibrium in supercooled glibenclamide drug: analysis of fragility behavior.超冷格列本脲药物中质子转移平衡对压力的影响:分析脆弱行为。
J Phys Chem B. 2010 Nov 25;114(46):14815-20. doi: 10.1021/jp104444q. Epub 2010 Oct 28.
6
A classification system to assess the crystallization tendency of organic molecules from undercooled melts.一种评估有机分子从过冷熔体中结晶倾向的分类系统。
J Pharm Sci. 2010 Sep;99(9):3787-806. doi: 10.1002/jps.22197.
7
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.从计算得出的 Flory-Huggins 相互作用参数和相图预测无定形小分子二元混合物的形成和稳定性。
Mol Pharm. 2010 Jun 7;7(3):795-804. doi: 10.1021/mp900304p.
8
Molecular motions in amorphous ibuprofen as studied by broadband dielectric spectroscopy.通过宽带介电谱研究非晶态布洛芬中的分子运动。
J Phys Chem B. 2008 Sep 4;112(35):11087-99. doi: 10.1021/jp8040428. Epub 2008 Aug 8.
9
Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state.热力学、分子和动力学因素在非晶态结晶中的作用。
J Pharm Sci. 2008 Apr;97(4):1329-49. doi: 10.1002/jps.21138.
10
Dielectric relaxation of alpha -tocopherol acetate (vitamin E).
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Jan;75(1 Pt 1):011903. doi: 10.1103/PhysRevE.75.011903. Epub 2007 Jan 8.